Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Scientists at Theracrine patent novel agents for cancer

Feb. 12, 2013

New PI3Kgamma and delta inhibitors disclosed by Infinity Pharmaceuticals and Intellikine

Feb. 12, 2013

FDA approves second drug for multiple myeloma

Feb. 11, 2013

Data from phase II Reolysin trial in lung cancer reported

Feb. 11, 2013

TGFR-1 inhibitor prevents metastasis in animal models of breast cancer

Feb. 11, 2013

Bevacizumab improves survival in patients with cervical cancer

Feb. 11, 2013

Nihon University discloses novel apoptosis inducers

Feb. 11, 2013

biOasis' Transcend-Herceptin conjugate shows promising antitumor activity

Feb. 8, 2013

EMA grants accelerated assessment to trametinib application

Feb. 8, 2013

Transgenic medaka model developed for screening drugs targeting oncogenes

Feb. 8, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...